| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-703 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2011-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6305b1a0eff2033c1955b11927b16dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d32041e1cb5ddd360b3cbf9b70710774
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d8fb46a8ab9f715597e15a1c23fd42e |
| publicationDate |
2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2011298892-A1 |
| titleOfInvention |
Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner) |
| abstract |
The invention relates to pharmaceutical formulations, in particular to transdermal therapeutic systems, which are characterized in that no active substance crystallizes out at the interface between the removable release liner and the active-substance-containing matrix. The active substance is gestodene or a gestodene ester in supersaturated matrix polymer and/or ethynyl estradiol. The matrix is free from solubilizers, crystallization inhibitors and dispersants. |
| priorityDate |
2010-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |